2020 - Are You Protecting Employees During HPAPI Manufacturing?

In this webinar, Tom Evans, MS, CMMS, an expert in hazardous manufacturing controls, will discuss the planning, resources, and capabilities necessary to effectively produce a client’s highly potent active pharmaceutical ingredient (HPAPI) therapeutic, while effectively controlling the risk of exposure to operating personnel. Controlling exposure is a critical factor in successfully bringing many of today’s novel, highly potent drugs to the clinic and eventually to the commercial market. Successful manufacture of HPAPIs includes containment design and installation considerations, Best Industrial Hygiene Practices, Good Manufacturing Practices, and the process of characterizing, challenging, and verifying isolator performance.